Equity Profile
Post-Earnings Recap
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.65 | N/A | -30.26% |
management commentary, guidance changes, and full analysis available with Pro.
| -30.26% |
Tone: Defensive
Management acknowledged the difficulties faced in the quarter and indicated a cautious approach moving forward. They did not provide specific guidance for the upcoming period.
Management expressed concerns about market conditions affecting performance.
They highlighted challenges in supply chain and pricing pressures.
WESCO International's earnings report shows a significant miss on EPS, leading to a sharp decline in stock price. The company's management cited ongoing challenges in the market, including supply chain issues and pricing pressures, which contributed to the disappointing results. Investors reacted negatively, resulting in a 31.13% drop in stock value.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
Immunovant, Inc.